Shilpa Medicare Unit Receives GMP Certification from Austrian Regulator
1 report, 1 independent
Updated Oct 10
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AGES, Austria, inspected Shilpa Medicare Limited's Unit 4 in Jadcherla, Telangana, India, between July 27 and July 30, 2026. Following the inspection, the unit was issued GMP Certification by AGES, Austria. This unit is responsible for manufacturing, testing, and distributing sterile Injections and non-sterile tablets and Capsule finished dosage forms for European and global markets.
From equitybulls.com
Why it matters
The successful GMP Certification allows the unit to maintain and expand its market access within Europe. This regulatory approval is critical for the company's operations in the pharmaceutical distribution sector.
From equitybulls.com
Who's involved
- AustriaCountry where the regulatory inspection was conducted
Keep exploring
The entities involved
-
Europe
terrestrial continent located in north-western Eurasia
- Under the shadow of the Ceuta crisis, Pedro Sánchez is involved in managing the situation, which is currently facing allegations of a Muslim invasion. Morocco remains a key hub for European investment.
- Creotech is opening subsidiaries in France as part of Europe's developing rocket programs and launch vehicle initiatives.
-
Austria
country in Central Europe